Nanoviricides Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.55

+0.13 (+9.15%)

As of May 16, 2:26 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,920.6% upside

Low Target $21.60

Average Target $31.32

High Target $37.71

Current Price $1.55

Current
$1.55

Target
$31.32

$21.60 $31.32 avg $37.71

Scenario Analysis

Bear Case

$21.60

1,293.5%

Low target

Base Case

$31.32

+1,920.6%

Avg target

Bull Case

$37.71

+2,332.9%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.23

-30.5% from high

52-Week Low

$0.85

+82.4% from low

Target vs 52W High

$31.32

+1,304.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%